肾结石患者输尿管镜术后生活质量的纵向变化
本研究前瞻性纳入2017至2020年接受输尿管镜(URS)的肾或输尿管结石成人患者,在入组时及术后1、6、12个月完成PROMIS-29量表。入组时69例完成调查,多个维度评分与美国人群均值显著不同;入组至1个月仅疼痛干扰和疲劳改善,至12个月除抑郁症状外各维度均改善。作者认为PROMIS-29对URS患者健康相关生活质量变化有反应性。
要点
- 入组时69例完成PROMIS-29,疼痛干扰、疲劳、抑郁症状、焦虑、睡眠障碍及躯体功能与美国人群均值显著不同(均P<.05)。
- 入组至1个月仅疼痛干扰(P<.01)和疲劳(P=.03)改善。
- 入组至12个月除抑郁症状外各维度均改善(两两比较均P<.05)。
核心结论
- PROMIS-29对接受URS的肾结石患者健康相关生活质量变化有反应性,PROMIS评分改善可持续至12个月。
- 该信息可用于患者咨询,帮助指导恢复期的预期。
研究设计与样本
- 前瞻性研究,2017至2020年招募接受输尿管镜(URS)的肾或输尿管结石成人患者。
- 参与者在入组时及1、6、12个月完成PROMIS-29量表,评分以T分数报告并按美国人群标准化。
- 入组时共69例完成PROMIS-29调查。
主要发现
- 入组时与美国人群均值相比,躯体功能、疲劳、疼痛干扰、抑郁症状、焦虑和睡眠障碍评分显著不同(均P<.05),社会角色与活动参与能力无显著差异。
- 两两比较中,仅入组至1个月疼痛干扰(P<.01)和疲劳(P=.03)改善。
- 入组至12个月,除抑郁症状外所有维度均改善(两两比较均P<.05)。
临床怎么用
- 作者认为该信息可用于患者咨询,帮助指导恢复期的预期。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess alterations in health-related quality of life (HRQOL) in patients with nephrolithiasis, given the limited prospective data on patient reported outcomes following surgical intervention with ureteroscopy. METHODS: Adults with either a renal or ureteral calculus who underwent ureteroscopy (URS) were recruited prospectively from 2017-2020. Participants completed the PROMIS-29 profile which measures the dimensions of physical function, fatigue, pain interference, depressive symptoms, anxiety, ability to participate in social roles and activities, and sleep disturbance at enrollment, 1-, 6-, and 12-months. Scores are reported as T-scores (normalized to US-population) and were compared at each time point against the mean for the US-population (50) using one-sample Welch's t'test and between each pairwise time point comparison using a Wilcoxon signed rank test. RESULTS: At enrollment, a total of 69 participants completed the PROMIS-29 survey. As compared to the US-population mean, participants at enrollment had significantly different scores in physical function, fatigue, pain interference, depressive symptoms, anxiety, and sleep disturbance (all P<.05), but not ability to participate in social roles and activities. In pairwise comparisons, improvement was only observed from enrollment to 1-month in pain interference (P<.01) and fatigue (P = .03). However, there was improvement at a longer interval from enrollment to 12-months in all dimensions (pairwise comparisons, all P<.05) except depressive symptoms. CONCLUSION: The PROMIS-29 profile is responsive to changes in HRQOL for patients with nephrolithiasis undergoing URS, with improvement of PROMIS scores up to 12-months. This information can be utilized for patient counseling to guide expectations during the recovery period.
引用
- Sperling CD, Chelluri R, Dobbs RW, et al. Longitudinal Changes in Quality of Life After Ureteroscopy for Nephrolithiasis. Urology. 2022. PMID: 36058341. doi:10.1016/j.urology.2022.08.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。